Comparison of Tiotropium Inhalation Capsules and Oxitropium Metered Dose Inhalator (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02172430 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium powder inhalation capsules
DRUG: Tersigan®

Sponsor

Boehringer Ingelheim